Kelly E Rentscher
Overview
Explore the profile of Kelly E Rentscher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hansen J, Carroll J, Seeman T, Cole S, Rentscher K
Brain Behav Immun
. 2024 Oct;
123:1159-1168.
PMID: 39442637
Psychosocial stress and adversity have been linked to accelerated aging and increased risk for age-related diseases. Animal and in vitro studies have shown that exposure to stress hormones (catecholamines, glucocorticoids)...
2.
Artese A, Zhou X, Tometich D, Small B, Ahles T, Ahn J, et al.
J Natl Cancer Inst
. 2024 Aug;
116(12):2009-2021.
PMID: 39107910
Background: Physical activity can improve cognition; however, little is known regarding the relationships between longitudinal objectively measured physical activity, cognition, and inflammation in older breast cancer survivors. Methods: Older (aged...
3.
Mandelblatt J, Dage J, Zhou X, Small B, Ahles T, Ahn J, et al.
J Natl Cancer Inst
. 2024 May;
116(9):1495-1507.
PMID: 38788675
Purpose: We evaluated whether plasma Alzheimer disease (AD)-related biomarkers were associated with cancer-related cognitive decline among older breast cancer survivors. Methods: We included survivors aged 60-90 years with primary stage...
4.
McDeed A, Van Dyk K, Zhou X, Zhai W, Ahles T, Bethea T, et al.
JNCI Cancer Spectr
. 2024 Mar;
8(2).
PMID: 38556480
Purpose: Cancer survivors commonly report cognitive declines after cancer therapy. Due to the complex etiology of cancer-related cognitive decline (CRCD), predicting who will be at risk of CRCD remains a...
5.
Kaplan D, Tidwell C, Chung J, Alisic E, Demiray B, Bruni M, et al.
Behav Res Methods
. 2023 Dec;
56(4):3207-3225.
PMID: 38066394
Ambient audio sampling methods such as the Electronically Activated Recorder (EAR) have become increasingly prominent in clinical and social sciences research. These methods record snippets of naturalistically assessed audio from...
6.
Nakamura Z, Small B, Zhai W, Ahles T, Ahn J, Artese A, et al.
J Cancer Surviv
. 2023 Nov;
PMID: 37924476
Purpose: To identify trajectories of depressive symptoms in older breast cancer survivors and demographic, psychosocial, physical health, and cancer-related predictors of these trajectories. Methods: Recently diagnosed nonmetastatic breast cancer survivors...
7.
Palitsky R, Chen Z, Rentscher K, Friedman S, Wilson D, Ruiz J, et al.
Aging Cell
. 2023 Oct;
23(1):e14014.
PMID: 37840393
Bereavement increases in prevalence as people age and is associated with multiple psychological and health risks, including cardiovascular risk. Religious and existential variables may play an important role in the...
8.
Rentscher K, Klopack E, Crimmins E, Seeman T, Cole S, Carroll J
Brain Behav Immun
. 2023 Sep;
114:349-359.
PMID: 37683960
Growing evidence suggests that social relationship quality can influence age-related health outcomes, although how the quality of one's relationships directly relates to the underlying aging process is less clear. We...
9.
Rentscher K, Bethea T, Zhai W, Small B, Zhou X, Ahles T, et al.
Cancer
. 2023 Jun;
129(17):2741-2753.
PMID: 37259669
Background: Cancer and its treatments may accelerate aging in survivors; however, research has not examined epigenetic markers of aging in longer term breast cancer survivors. This study examined whether older...
10.
Mandelblatt J, Small B, Zhou X, Nakamura Z, Cohen H, Ahles T, et al.
Cancer
. 2023 Apr;
129(15):2409-2421.
PMID: 37096888
Background: Immune activation/inflammation markers (immune markers) were tested to explain differences in neurocognition among older breast cancer survivors versus noncancer controls. Methods: Women >60 years old with primary breast cancer...